VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 166 filers reported holding VIR BIOTECHNOLOGY INC in Q2 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $470,964 | +36.4% | 50,263 | +257.2% | 0.02% | +38.5% |
| Q2 2023 | $345,162 | -85.2% | 14,071 | -86.0% | 0.01% | -86.6% |
| Q1 2023 | $2,337,541 | +129.2% | 100,453 | +149.3% | 0.10% | +79.6% |
| Q4 2022 | $1,019,765 | +214.7% | 40,291 | +139.8% | 0.05% | +315.4% |
| Q3 2022 | $324,000 | -48.4% | 16,800 | -31.2% | 0.01% | -51.9% |
| Q1 2022 | $628,000 | -64.1% | 24,414 | -33.9% | 0.03% | -84.0% |
| Q2 2021 | $1,747,000 | -8.6% | 36,951 | -0.9% | 0.17% | -5.6% |
| Q1 2021 | $1,912,000 | +146.7% | 37,300 | +28.8% | 0.18% | +35.6% |
| Q4 2020 | $775,000 | – | 28,949 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $36,281,234 | 32.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 18,319,938 | $426,304,957 | 3.50% |
| Zebra Capital Management LLC | 27,110 | $631 | 3.15% |
| Avidity Partners Management LP | 1,640,200 | $38,167,454 | 1.27% |
| Sofinnova Investments, Inc. | 657,559 | $15,301,398 | 0.98% |
| DCF Advisers, LLC | 62,000 | $1,442,740 | 0.88% |
| SECTOR GAMMA AS | 145,545 | $3,386,832 | 0.82% |
| Temasek Holdings (Private) Ltd | 5,814,972 | $135,314,398 | 0.80% |
| BRAIDWELL LP | 604,036 | $14,055,918 | 0.46% |
| SummerHaven Investment Management, LLC | 26,045 | $606,067 | 0.35% |